The Efficacy of Susceptibility Test -Driven Sequential Therapy as the Third Line Therapy for Refractory Helicobacter Pylori Infection
Interventional
Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Eradication rate will be evaluated according to Intent-to-treat (ITT) and per-protocol (PP) analyses
2009/04/20
No
Jyh-Ming Liou, MD
Principal Investigator
National Taiwan University Hospital
Taiwan: Department of Health
200901042M
NCT01032655
April 2009
March 2012
Name | Location |
---|